Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation

被引:811
作者
Bours, M. J. L.
Swennen, E. L. R.
Di Virgilio, F.
Cronstein, B. N.
Dagnelie, P. C.
机构
[1] Maastricht Univ, Dept Epidemiol, Nutr & Toxicol Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Dept Pharmacol & Toxicol, Nutr & Toxicol Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[3] Univ Ferrara, Dept Expt & Diagnost Med, Sec Gen Pathol, I-44100 Ferrara, Italy
[4] NYU, Sch Med, Dept Med, Div Clin Pharmacol, New York, NY 10016 USA
关键词
ATP; adenosine; purinergic receptors; immunity; inflammation;
D O I
10.1016/j.pharmthera.2005.04.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human health is under constant threat of a wide variety of dangers, both self and nonself. The immune system is occupied with protecting the host against such dangers in order to preserve human health. For that purpose, the immune system is equipped with a diverse array of both cellular and non-cellular effectors that are in continuous communication with each other. The naturally occurring nucleotide adenosine 5'-triphosphate (ATP) and its metabolite adenosine (Ado) probably constitute an intrinsic part of this extensive immunological network through purinergic signaling by their cognate receptors, which are widely expressed throughout the body. This review provides a thorough overview of the effects of ATP and Ado on major immune cell types. The overwhelming evidence indicates that ATP and Ado are important endogenous signaling molecules in immunity and inflammation. Although the role of ATP and Ado during the course of inflammatory and immune responses in vivo appears to be extremely complex, we propose that their immunological role is both interdependent and multifaceted, meaning that the nature of their effects may shift from immunostimulatory to immunoregulatory or vice versa depending on extracellular concentrations as well as on expression patterns of purinergic receptors and ecto-enzymes. Purinergic signaling thus contributes to the fine-tuning of inflammatory and immune responses in such a way that the danger to the host is eliminated efficiently with minimal damage to healthy tissues. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:358 / 404
页数:47
相关论文
共 755 条
  • [1] METABOLISM OF EXTRACELLULAR ADENINE-NUCLEOTIDES BY HUMAN ENDOTHELIAL-CELLS EXPOSED TO REACTIVE OXYGEN METABOLITES
    AALTO, TK
    RAIVIO, KO
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02): : C282 - C286
  • [2] Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
    Abbracchio, MP
    Boeynaems, JM
    Barnard, EA
    Boyer, JL
    Kennedy, C
    Miras-Portugal, MT
    King, BF
    Gachet, C
    Jacobson, KA
    Weisman, GA
    Burnstock, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) : 52 - 55
  • [3] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [4] Mechanisms of phagocytosis in macrophages
    Aderem, A
    Underhill, DM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 593 - 623
  • [5] P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
    Adinolfi, E
    Melchiorni, L
    Falzoni, S
    Chiozzi, P
    Morelli, A
    Tieghi, A
    Cuneo, A
    Castoldi, G
    Di Virgilio, F
    Baricordi, OR
    [J]. BLOOD, 2002, 99 (02) : 706 - 708
  • [6] Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells
    Adrian, K
    Bernhard, MK
    Breitinger, HG
    Ogilvie, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01): : 127 - 138
  • [7] Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages
    Aga, M
    Watters, JJ
    Pfeiffer, ZA
    Wiepz, GJ
    Sommer, JA
    Bertics, PJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 286 (04): : C923 - C930
  • [8] Aga M, 2002, J LEUKOCYTE BIOL, V72, P222
  • [9] Adenosine triphosphate - Established and potential clinical applications
    Agteresch, HJ
    Dagnelie, PC
    van den Berg, JWO
    Wilson, JHP
    [J]. DRUGS, 1999, 58 (02) : 211 - 232
  • [10] CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism
    Airas, L
    Niemelä, J
    Jalkanen, S
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (10) : 5411 - 5417